A prospective evaluation of tolerability of niraparib dosing based upon baseline body weight (wt) and platelet (blplt) count: Blinded pooled interim safety data from the PRIMA Study

Journal article

Open access

Peer reviewed

A. Gonzalez, M.R. Mirza, I. Vergote, Y. Li, S. Hazard, R. Clark, W. Graybill, B. Pothuri and B.J. Monk

Annals of oncology, Vol.29, pp.viii335-viii336

10/2018

PMID: 32136793

Files and links (1)

url

https://doi.org/10.1093/annonc/mdy285.150View

Published (Version of record) Open

4 Record Views

Title: A prospective evaluation of tolerability of niraparib dosing based upon baseline body weight (wt) and platelet (blplt) count: Blinded pooled interim safety data from the PRIMA Study
Creators: A. Gonzalez - Clinica Universidad de Navarra
M.R. Mirza - Nordic Society of Gynecologic Oncology
I. Vergote - KU Leuven
Y. Li - Tesaro
S. Hazard - Tesaro
R. Clark - Tesaro
W. Graybill - Medical University of South Carolina
B. Pothuri - NYU Langone Health
B.J. Monk - Creighton University
Publication Details: Annals of oncology, Vol.29, pp.viii335-viii336
Publisher: Elsevier Ltd
Identifiers: 991005969033002656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article